Variables PCI patients(n=136)
Male,n(%) 106(77.9)
Age at PCI,years(±SD) 57.18±8.041
Body mass index,Kg/m2(±SD) 23.91±1.456
Body surface area(m2) (±SD) 1.70±0.207
Comorbidities
hypertension,n(%) 34(25.0)
diabetes,n(%) 27(19.8)
Stoke/TIA 14(10.2)
hyperlipemia,n(%) 23(16.9)
Vessels with> 70% stenotic lesion
LAD,n(%) 106(77.9)
LCX,n(%) 20(14.7)
RCA,n(%) 39(28.7)
Number of affected vessels≥2,n(%) 41(30.1)
Smoker,n(%) 48(35.3)
TC 2.09±0.317
LDL 2.20±0.436
NT-pro-BNP 116(84,233)
NYHA classification≥2,n(%) 118(86.8)
Medication post-PCI
Aspirin,n(%) 130(95.6)
Clopidogrel,n(%) 127(93.4)
Beta blocker,n(%) 122(89.7)
Statin ,n(%) 136(100)
ACEI or ARB,n(%) 126(92.6)